Tourmaline Bio, Inc.
TRML · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73 | -$42 | -$20 | -$48 |
| Dep. & Amort. | $0 | $0 | $0 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $6 | $0 | $0 |
| Change in WC | -$3 | -$0 | $1 | $2 |
| Other Non-Cash | -$8 | $8 | $12 | $5 |
| Operating Cash Flow | -$77 | -$28 | -$6 | -$40 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | -$5 | $0 |
| Inv. Purchases | -$366 | -$17 | $0 | -$276 |
| Inv. Sales/Matur. | $172 | $21 | $0 | $182 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$194 | $4 | -$5 | -$96 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | $0 |
| Stock Issued | $161 | $70 | $20 | $138 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $86 | $20 | -$0 |
| Financing Cash Flow | $161 | $157 | $20 | $137 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$110 | $132 | $8 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $141 | $8 | $0 | $18 |
| End Cash | $31 | $141 | $8 | $19 |
| Free Cash Flow | -$77 | -$28 | -$12 | -$42 |